Meyka Pro banner
cbdMD, Inc.

cbdMD, Inc. (YCBD-PA) Stock Overview

Explore cbdMD, Inc.’s financial performance, market position, analyst ratings, and future outlook.

YCBD-PAAMEX
HealthcareDrug Manufacturers - Specialty & Generic
$1.35
$0.21(18.51%)
U.S. Market opens in 64h 15m

cbdMD, Inc. (YCBD-PA)

Meyka AI Score

Z

Key Financials

Market Cap928.2K
P/E Ratio-1.42
EPS (TTM)$-0.50
ROE-0.34%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.83

YCBD-PA Stock Analysis & Investment Overview (AMEX)

Our AI-powered analysis of cbdMD, Inc. (AMEX: YCBD-PA) gives investors deep insight into how the stock performs on the AMEX exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, cbdMD, Inc.'s AMEX-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of YCBD-PA on the AMEX shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $0.83 for the AMEX listing.

Key metrics behind cbdMD, Inc.'s AMEX-traded stock include a P/E ratio of -1.42 and a market capitalization of 928.2K. Combined with our AI analysis, these give both institutional and retail investors a clear view of YCBD-PA on the AMEX.

Price Performance (AMEX: YCBD-PA)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
18.73%
3-Month Change
73.13%
6-Month Change
7.42%
Year-to-Date (YTD) Change
64.07%
1-Year Change
83.66%
3-Year Change
-67.70%
5-Year Change
-84.28%
All-Time (Max) Change
-85.29%

Contact Information

704 445 3060
8845 Red Oak Boulevard, Charlotte, NC, 28217

Company Facts

420 Employees
IPO DateOct 21, 2019
CountryUS

Frequently Asked Questions